To promote collaborative work between kidney care professionals in the multidisciplinary team, the British Renal Society has a number of affiliate groups. Two of these groups are the Renal Nutrition Specialist Group and the Renal Rehabilitation Network. In this column, chairs Harriet Williams and Sharlene Greenwood discuss recent and ongoing projects in their respective fields.
We can't get away from the importance of certain lifestyle choices, including adequate exercise and a healthy diet. This is all the more significant for kidney patients, argues Nicholas Palmer, who must do their best to avoid unhealthy temptations and be aware of the risks that exist.
Patients on haemodialysis have an increased risk of developing diabetic foot problems, as well as difficulties in accessing specialist care. This service evaluation assessed whether educating haemodialysis nurses in foot care resulted in more frequent examination. It also considered whether improvements in patients' self-care behaviour associated with their feet were reported.
Journal of Renal NursingVol. 8, No. 1 RegularsHow the nephron works—it's a filter Physiologists resolve an anatomical impasseNeil TurnerNeil TurnerSearch for more papers by this authorNeil TurnerPublished Online:28 Jan 2016https://doi.org/10.12968/jorn.2016.8.1.50AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View articleFurther informationTurner AN (2016) History of Nephrology blog http://bit.ly/1ijMLYr (accessed 15 January 2016) Google ScholarJamison RL (2014) Resolving an 80-yr-old controversy: the beginning of the modern era of renal physiology. Adv Physiol Educ 38(4): 286–95 Crossref, Google ScholarAbout Frederick Ruysch (1638-1731): http://bit.ly/N44GCe (accessed 15 January 2016) Google Scholar FiguresReferencesRelatedDetails 2 January 2016Volume 8Issue 1ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 28 January 2016 Published in print 2 January 2016 Information© MA Education LimitedPDF download
The variety, format and availability of phosphate binders has increased greatly over recent years. In this article, renal dietitian Nick McAleer discusses what phosphate is, what role it has within the body, and the implications of poor phosphate control—especially for renal patients. He also outlines key recommendations from national guidance on phosphate management.
Journal of Renal NursingVol. 8, No. 2 RegularsBright's disease: 100 years after BrightThe last decade of purely clinical observationNeil TurnerNeil TurnerSearch for more papers by this authorNeil TurnerPublished Online:23 Mar 2016https://doi.org/10.12968/jorn.2016.8.2.102AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article FiguresReferencesRelatedDetails 2 March 2016Volume 8Issue 2ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 23 March 2016 Published in print 2 March 2016 Information© MA Healthcare LimitedPDF download
Kidney Research UK invested £5.1 million in 2014–2015 to drive forward new research. In this month's article, Angela Lumsdon describes a new funding opportunity for health professionals and features the experiences of Drs Nicola Thomas and Lesley Lappin, who both received research funding to improve and develop what is known about kidney care.
Autosomal dominant polycystic kidney disease is the most common and severe form of polycystic kidney disease. Although patients may display similar symptoms, the management of each individual will pose different challenges for the renal nurse. A hoslitic approach and understanding, argues Sarah Borrows, is vital to improve the wellbeing of patients and families.
Journal of Renal NursingVol. 8, No. 2 EditorialDiabetes and CKD: patient education is keyGeorgia Noble-BellGeorgia Noble-BellSearch for more papers by this authorGeorgia Noble-BellPublished Online:23 Mar 2016https://doi.org/10.12968/jorn.2016.8.2.56AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References National Institute for Health and Care Excellence (2014) Chronic Kidney Disease in Adults: Assessment and Management. http://bit.ly/1vYCINF (accessed 10 March 2016) Google ScholarNational Institute for Health and Care Excellence (2015) Type 2 Diabetes in Adults: Management. http://bit.ly/1PDex0p (accessed 10 March 2016) Google ScholarNHS Kidney Care (2011) Kidney Disease: Key Facts and Figures. http://bit.ly/1XeKrQE (accessed 10 March 2016) Google Scholar FiguresReferencesRelatedDetails 2 March 2016Volume 8Issue 2ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 23 March 2016 Published in print 2 March 2016 Information© MA Healthcare LimitedPDF download
To promote collaborative work between kidney care professionals in the multidisciplinary team, the British Renal Society has a number of affiliate groups. One such group is the UK Renal Pharmacy Group (RPG). In this column, the RPG's chair, Caroline Ashley, and the lead for research and development, Sue Shaw, discuss recent and ongoing projects in renal pharmacy.
As part of a series looking at Care Quality Commission (CQC) inspections, Peter Ellis and Jane Abbott consider the two key questions: is the service effective and caring, and what is needed to meet these requirements?. They look at the various areas that come within these categories, such as are staff aware of the needs of people with dementia, and does the service recognise diversity in all its forms?
The UK is renowned for its provision of high-quality end-of-life care. In the latest article in a series on palliative care, Aysha Mendes stresses the importance of renal nurses making use of the resources available to them, as these can help educate and encourage confidence.
In this issue's drug focus, Mee Onn Chai and Adrian Coleman describe the management of hypocalcaemia in a 41-year-old man with end-stage renal disease (ESRD), following a parathyroidectomy procedure using intravenous calcium.
Journal of Renal NursingVol. 8, No. 2 EditorialSpread the word about smoking cessationEmily ReeveEmily ReeveSearch for more papers by this authorEmily ReevePublished Online:23 Mar 2016https://doi.org/10.12968/jorn.2016.8.2.57AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Action on Smoking and Health (2015) Smoking statistics. http://bit.ly/1QS7nn7 (accessed 11 March 2016) Google Scholar FiguresReferencesRelatedDetails 2 March 2016Volume 8Issue 2ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 23 March 2016 Published in print 2 March 2016 Information© MA Healthcare LimitedPDF download
On 11 February 2016, the Medicines and Healthcare Products Regulatory Agency announced that nivolumab, a new medicine for advanced renal cell carcinoma, will be available via the Early Access to Medicines Scheme. Kim Edmonds discusses the impact of this for patients with kidney cancer.
Journal of Renal NursingVol. 8, No. 1 EditorialInnovate, share, learn and communicateFiona LoudFiona LoudSearch for more papers by this authorFiona LoudPublished Online:28 Jan 2016https://doi.org/10.12968/jorn.2016.8.1.4AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References National Institute for Health and Care Excellence (2014) Kidney transplantation (adults)–immunosuppressive therapy (review of TA 85). http://tinyurl.com/gqrsn3a (accessed 13 January 2016) Google Scholar FiguresReferencesRelatedDetails 2 January 2016Volume 8Issue 1ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 28 January 2016 Published in print 2 January 2016 Information© MA Education LimitedPDF download
A major part of the success of modern kidney transplantation is the development of immunosuppressive therapies, changing the landscape of practice and enabling increasingly complex recipients. In this comment piece, Lisa Burnapp discusses the impact of recent recommendations from the National Institute for Health and Care Excellence in relation to this.
Michelle Lam and Adrian Coleman describe the case of a 49-year-old male patient with chronic kidney disease stage 2, who developed acute kidney injury secondary to an episode of euglycaemic diabetic ketoacidosis, following the initiation of a loop diuretic.
Tolvaptan, a drug used to treat those with autosomal dominant polycystic kidney disease, is now officially recommended for use in England and Scotland. In this month's Kidney Research UK column, the charity's Research Communications Cfficer Rosie Loft explains the implications of this medication for the kidney care community.
Journal of Renal NursingVol. 8, No. 1 EditorialEvery nurse can improve end-of-life careSusan DewarSusan DewarSusan DewarPublished Online:28 Jan 2016https://doi.org/10.12968/jorn.2016.8.1.5AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References National Institute for Health and Care Excellence (2015) Care of Dying Adults in the Last Days of Life. NICE, London Google Scholar FiguresReferencesRelatedDetails 2 January 2016Volume 8Issue 1ISSN (print): 2041-1448ISSN (online): 2052-2894 Metrics History Published online 28 January 2016 Published in print 2 January 2016 Information© MA Education LimitedPDF download
